When talent meets purpose, extraordinary things happen. We're cultivating a workplace where every voice matters and every perspective is valued. Together, we're building careers with meaning while making a lasting difference to people living with severe diseases.? Discover a future where professional growth and patient impact go hand in hand. #MakeYourMarkForPatients #TeamUCB #PharmaJobs Learn more at UCB Careers?https://lnkd.in/dHkyid5y
关于我们
UCB – Inspired by patients. Driven by science. At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries of what is possible. With us, our talents makes the most of who they are, unlocking innovation and setting new standards for patients. Everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?” And to find the answers, we connect globally with patients and their families living with the physical and social burdens of severe disease. These connections give us new perspectives, drive our innovation, and offer a hope for a new generation of therapies that will help to transform lives. UCB – The Facts With more than 9000 employees in around 40 countries, we are a global biopharmaceutical company headquartered in Brussels, Belgium which invests more than 25% of revenue in cutting-edge scientific research to meet unmet patient needs. A few other reasons that make UCB an amazing place to work: - Promising pipeline that includes several novel molecules; - 2024 Key Financials: € 6.15 billion global revenue Specialties: Neurology, Immunology
- 网站
-
https://www.ucb.com
优时比的外部链接
- 所属行业
- 制药业
- 规模
- 5,001-10,000 人
- 总部
- Brussels
- 类型
- 私人持股
- 创立
- 1928
- 领域
- Neurology、Immunology和Healthcare Innovation Beyond Medicine
地点
优时比员工
动态
-
To bridge the gap between medical professionals and those living with chronic conditions, we must learn from their experiences. By listening to different perspectives to inform our research, we can work to transform groundbreaking science into life-changing treatments. ??? We caught up with UCB colleagues at congresses earlier this year to explore how these partnerships lead to better outcomes. #UCB #Patients
-
Today, on #IWD2025, UCB stands with women around the world to #AccelerateAction to emphasise the importance of taking steps towards greater representation of women in clinical trials. ? Read more from Marie Teil today!
Pharmaceutical Executive with 20+ years of experience | Global Head, Women of Childbearing Age Program @ UCB | Dedicated to advancing science in women's health.
As we gear up to celebrate International Women’s Day 2025, I’m proud and inspired by the progress UCB is making to support this year’s theme, #AccelerateAction. Our commitment to including women of childbearing age in clinical trials is a crucial step toward ensuring that every woman has access to the best possible care. Learn more: https://bit.ly/4iuHSd4 How will you help #AccelerateAction today? Let me know in the comments! #IWD2025 #TeamUCB
-
-
?Hidradenitis Suppurativa (HS): Did you know?? Beyond the visible symptoms of #HS, such as lumps and abscesses, those living with this condition often experience stigma. This can impact mental well-being which can have wide-reaching effects on many areas of life, including relationships, education, and careers. At UCB, we know that not all battles are visible. We stand united with the HS community in our mission to raise awareness. Together, we can make a difference. https://lnkd.in/ekFB8n_N
-
-
UCB is in Orlando, Florida for the #AAD2025 global congress. This year, we are delighted to present our focused research across immune-mediated dermatological indications.? We are looking forward to connecting with the dermatology community and discussing how we can enhance the standard of care in conditions like #HidradenitisSuppurativa (HS) and #Psoriasis.? ?? Click to find out more about what we’re up to for #AAD2025?? https://lnkd.in/eviHgzSd
-
As this year’s International Women’s Day approaches, at UCB we reinforce our commitment to fostering a thriving and inclusive workplace where every colleague feels valued, respected and empowered. Because we believe that only if colleagues are happy, inspired and healthy, will they contribute to discovering and delivering innovative solutions to people living with severe diseases. #InternationalWomensDay #IWD2025 #womeninpharma #inclusion
-
-
Imagine you are caring for your loved one who lives with Dravet Syndrome or Lennox-Gastaut Syndrome, there’s no easy way to keep track of everything – medicine doses and schedules, care guidance, seizure and symptom tracking – all in one place. You need one solution designed to consolidate this important information, as well as a tool to monitor their own mental wellbeing. Introducing CareCompass – a digital solution designed for people living with rare epilepsies and their care community. A consolidated platform aiming to create more peace of mind for caregivers. Read more about how UCB is driving patient-centered digital care initiatives: https://lnkd.in/ejeYaUai #DigitalCareTransformation #CareCompass #UCB
-
优时比转发了
Today is #RareDiseaseDay! An important day for the rare disease community as we unite in solidarity with millions worldwide to spread awareness and knowledge of the impact of living with a #RareDisease.? Approximately, 300 million people live with a rare disease across the Globe. About 95% of rare conditions still lack appropriate treatments - it is becoming ever more important to increase awareness. At UCB, our philosophy is driven by our dedication to overcoming the barriers that prevent early and sustainable access to health, social care, diagnosis and treatment. In tackling these obstacles, we can support patients in reducing the burden of their condition and help them to live the best life possible.? Join us in our mission and visit: www.rarediseaseday.org
-
-
For our first participation in the Best Employers Survey in Switzerland, we are very proud to be among the 10 most attractive companies in Switzerland in 2025 and in 1st position in the ranking of the Chemicals/Pharmaceuticals sector. ‘This success reflects the constant commitment and passion of every employee at UCB in Bulle, who work together to create an exceptional place to work’, Fabrice Vericel, Head of UCB Bulle Site. Out of more than 1,500 companies pre-selected on the basis of an independent survey of more than 240,000 opinions, UCB is ranked 10th in the list of the 250 best employers in Switzerland in 2025. Click on the following links to access to the UCB portrait: -??????in German: Beste Arbeitgeber der Schweiz 2025: Bei UCB lebt man eine famili?re Firmenkultur | Handelszeitung https://lnkd.in/ezRrMgeX -??????in French: Chez UCB, on vit une culture d’entreprise familiale | PME https://lnkd.in/eZ7K7t9u This recognition is the result of our strategy focused on creating a positive impact on people. It highlights our mission: Inspired by patients, guided by science. To find out more about UCB in Switzerland and explore job opportunities, visit our website: www.ucbsuisse.ch? ????? #BestEmployersSwitzerland #Handelszeitung #PME
-
-
"Rare" doesn't mean "impossible." UCB is proud to be part of the RealiseD_IHI project where, in collaboration, we aim to develop cutting-edge operational and methodological tools and resources that can dramatically advance the evaluation of new treatments for rare and ultra-rare diseases. Can we rewrite the rules of clinical trials?? ? Read more here https://lnkd.in/epeJTGBB to learn about this project.?
-